StoneX Group Inc. SNEX OTC derivative brokerage — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by StoneX Group Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: StoneX Group Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about StoneX Group Inc.'s otc derivative brokerage — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is StoneX Group Inc.'s OTC derivative brokerage — revenue?
- StoneX Group Inc. (SNEX) reported OTC derivative brokerage — revenue of $1.6M in Q1 2026.
- How has StoneX Group Inc.'s OTC derivative brokerage — revenue changed year-over-year?
- StoneX Group Inc.'s OTC derivative brokerage — revenue decreased by 36.0% year-over-year, from $2.5M to $1.6M.
- What is the long-term trend for StoneX Group Inc.'s OTC derivative brokerage — revenue?
- Over 4 years (2021 to 2025), StoneX Group Inc.'s OTC derivative brokerage — revenue has grown at a -8.8% compound annual growth rate (CAGR), from $15.9M to $11M.
- What does OTC derivative brokerage — revenue mean?
- The total revenue earned from facilitating and brokering over-the-counter derivative transactions for clients.
- How do you interpret OTC derivative brokerage — revenue?
- An increase suggests higher client activity or improved market share in OTC derivative execution, while a decrease may indicate reduced trading volumes or increased competition in the OTC space.
- How does OTC derivative brokerage — revenue compare across companies?
- Comparable to commission and fee-based revenue from OTC trading desks at other global brokerage and financial services firms.